REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Urolaser Kennedy S.A. (Ecuador)

Main Activities: General Medical and Surgical Hospitals
Full name: Urolaser Kennedy S.A. Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Urolaser Kennedy S.A. is based in Ecuador. The head office is in Guayaquil. The company operates in the General Medical and Surgical Hospitals industry. It was established on March 26, 2009. 4 (2023) employees currently work for Urolaser Kennedy S.A.. The latest financial highlights indicate a net sales revenue increase of 23.12% in 2023. Over the same period, its total assets grew by 27.01%.

Headquarters
Av. San Jorge 805, Clinica Kennedy Seccion Alfa Bldg. , Floor 5
Guayaquil; Guayas;

Contact Details: Purchase the Urolaser Kennedy S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Urolaser Kennedy S.A. report to view the information.
Outstanding Shares:
Purchase the Urolaser Kennedy S.A. report to view the information.
Registered Capital:
Purchase the Urolaser Kennedy S.A. report to view the information.
Incorporation Date:
March 26, 2009
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
46%
Purchase this report to view the information.
44%
Purchase this report to view the information.
10%
Company Performance
Financial values in the chart are available after Urolaser Kennedy S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
23.12%▲
Total operating revenue
23.12%▲
Operating profit (EBIT)
3949.29%▲
EBITDA
309.97%▲
Net Profit (Loss) for the Period
N/A
Total assets
27.01%▲
Total equity
21.64%▲
Operating Profit Margin (ROS)
30.59%▲
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
-5.05%▼
Cash Ratio
-2.78%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo